1 tablish a novel method to evaluate drugs for anaphylactoid reactions.

2 e potential and strength of allergen-induced anaphylactoid reactions.

3 ation of drugs or components that may induce anaphylactoid reactions.

4 amma receptor (FcgammaR) IIa in IVIg-induced anaphylactoid reactions.

5 ine regimen resulted in less vomiting, fewer anaphylactoid reactions, and reduced need for treatment

6                                              Anaphylactoid reactions are common clinical acute advers

7 This LAD2 release model was used to evaluate anaphylactoid reactions induced by ciprofloxacin, norflo

8 les of MRGPRX2 on host defense, drug-induced anaphylactoid reactions, neurogenic inflammation, pain,

9                                      She had anaphylactoid reactions on administration of intravenous

10 us events, such as seizures, anaphylactic or anaphylactoid reactions, serum sickness, and thrombocyto

11         All 14 patients with anaphylactic or anaphylactoid reactions survived.

12 pplies worldwide, is the cause of the severe anaphylactoid reactions that have occurred after intrave

13 associated with systemic pseudo-allergic, or anaphylactoid, reactions; we show that drug-induced symp

14                                       Severe anaphylactoid reactions were recorded in five patients a